Welltower Inc. $WELL is Uniplan Investment Counsel Inc.'s 3rd Largest Position

Key Points

• Uniplan Investment Counsel Inc. reduced its stake in Welltower Inc. by 6.7%, resulting in ownership of 320,165 shares valued at approximately $49 million.
• Welltower recently announced a dividend increase to $0.74 per share, up from $0.67, reflecting a yield of 1.8%.
• Welltower's quarterly earnings exceeded expectations with $1.28 EPS on revenue of $2.55 billion, marking a 39.6% year-over-year increase.

Uniplan Investment Counsel Inc. lessened its position in Welltower Inc. (NYSE:WELL - Free Report) by 6.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 320,165 shares of the real estate investment trust's stock after selling 22,873 shares during the period. Welltower comprises approximately 4.8% of Uniplan Investment Counsel Inc.'s holdings, making the stock its 3rd biggest holding. Uniplan Investment Counsel Inc.'s holdings in Welltower were worth $49,053,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in WELL. Brighton Jones LLC grew its holdings in shares of Welltower by 7.1% during the fourth quarter. Brighton Jones LLC now owns 4,185 shares of the real estate investment trust's stock worth $527,000 after purchasing an additional 279 shares during the last quarter. Baird Financial Group Inc. boosted its stake in Welltower by 7.0% in the fourth quarter. Baird Financial Group Inc. now owns 11,914 shares of the real estate investment trust's stock valued at $1,502,000 after acquiring an additional 784 shares during the last quarter. Cary Street Partners Financial LLC acquired a new position in Welltower in the fourth quarter valued at about $169,000. Cresset Asset Management LLC acquired a new stake in Welltower in the fourth quarter worth $713,000. Finally, EP Wealth Advisors LLC boosted its position in shares of Welltower by 18.9% during the fourth quarter. EP Wealth Advisors LLC now owns 4,157 shares of the real estate investment trust's stock worth $524,000 after purchasing an additional 661 shares in the last quarter. Institutional investors and hedge funds own 94.80% of the company's stock.

Insider Buying and Selling at Welltower

In other Welltower news, Director Andrew Gundlach bought 20,000 shares of Welltower stock in a transaction dated Monday, June 30th. The stock was purchased at an average price of $151.46 per share, for a total transaction of $3,029,200.00. Following the completion of the purchase, the director directly owned 20,000 shares of the company's stock, valued at approximately $3,029,200. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.21% of the company's stock.

Wall Street Analyst Weigh In

WELL has been the subject of several research analyst reports. Raymond James Financial reiterated a "strong-buy" rating on shares of Welltower in a report on Tuesday, September 2nd. Evercore ISI increased their target price on Welltower from $162.00 to $175.00 and gave the stock an "in-line" rating in a report on Wednesday, July 30th. Scotiabank lifted their price target on Welltower from $172.00 to $181.00 and gave the company an "outperform" rating in a research note on Thursday, August 28th. Finally, Wells Fargo & Company upped their price objective on Welltower from $175.00 to $185.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $175.00.

Welltower Stock Down 0.4%

WELL traded down $0.73 during midday trading on Wednesday, hitting $168.12. The company had a trading volume of 2,031,974 shares, compared to its average volume of 2,888,683. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.44. Welltower Inc. has a 52 week low of $122.34 and a 52 week high of $171.09. The stock's 50 day moving average price is $162.81 and its 200 day moving average price is $154.09. The company has a market capitalization of $112.44 billion, a price-to-earnings ratio of 94.98, a PEG ratio of 1.91 and a beta of 0.93.

Welltower (NYSE:WELL - Get Free Report) last issued its earnings results on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.22 by $0.06. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The company had revenue of $2.55 billion for the quarter, compared to analysts' expectations of $2.49 billion. During the same period last year, the business earned $1.05 EPS. Welltower's quarterly revenue was up 39.6% compared to the same quarter last year. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. On average, research analysts anticipate that Welltower Inc. will post 4.88 earnings per share for the current fiscal year.

Welltower Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 21st. Shareholders of record on Tuesday, August 12th were paid a $0.74 dividend. The ex-dividend date was Tuesday, August 12th. This is a positive change from Welltower's previous quarterly dividend of $0.67. This represents a $2.96 dividend on an annualized basis and a yield of 1.8%. Welltower's dividend payout ratio is presently 167.23%.

Welltower Profile

Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.